Twist Bioscience Corp at Barclays Global Healthcare Conference Transcript
Yeah.
Good afternoon everybody. I'm Luke Serga. I cover Life Science tools and diagnostics for Barclays. With me, I have Emily La Proust, CEO of Twist, and Adam Laponis, CFO, long time, it's, we've been doing this, so again, appreciate you for making it down and, Miami in March, as we were saying is not too bad, but, I guess from the jump and let's talk about The resegmentation into the syn bio plus the protein solutions, and how you guys are an AI winner and this is kind of how like I've been a big theme across the space of why.
Questions & Answers
Because you're not, there's not a clawed plug-in for you guys. Like, how are you guys the AI winner and walk through the kind of the resegmentation, how that fits in with that?
Yeah, no, thanks for having us. Thanks for your question. It's definitely one area where we have
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
